Stockscreener 앱 받기
1.61
6.62%
0.10
전일 마감가:
$1.51
열려 있는:
$1.52
하루 거래량:
630.61K
Relative Volume:
1.80
시가총액:
$23.91M
수익:
$43.20M
순이익/손실:
$-11.09M
주가수익비율:
-1.452
EPS:
-1.1088
순현금흐름:
$-9.32M
1주 성능:
+1.26%
1개월 성능:
+31.97%
6개월 성능:
+79.67%
1년 성능:
+91.92%
1일 변동 폭
$1.52
$1.63
1주일 범위
$1.48
$1.63
52주 변동 폭
$0.5547
$1.63
Biofrontera Inc Stock (BFRI) Company Profile
명칭
Biofrontera Inc
전화
781-245-1325
주소
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.61 | 21.98M | 43.20M | -11.09M | -9.32M | -1.1088 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Biofrontera Inc 주식(BFRI)의 최신 뉴스
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - Vinanet
Ziopharm: Q2 Earnings Snapshot - AOL.com
Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn
Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance
Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan
Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BFRI Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 6.4% Stock RallyEarnings Weakness Phase - vinanet.vn
Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review
Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com
BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative
Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times
Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeSuperTrend - vinanet.vn
Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada
Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore
BFRI Q1 2026 Earnings: EPS Misses Estimates by 215%, Shares Edge Down 0.8%EPS Miss Report - vinanet.vn
BFRI Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - The Manila Times
Biofrontera schedules Aug. 13 webcast for business update - Stock Titan
Biofrontera (BFRI) Q1 2026 Earnings: Deep EPS Miss Reflects Rising Costs and Pipeline PressureRevenue Growth Outlook - vinanet.vn
BFRI Q2'26 Earnings: revenue estimate is 9.50M USD - TradingView
Form 4 Biofrontera Inc For: 29 July By Investing.com - Investing.com Canada
Biofrontera Inc. (BFRI) Q1 2026 Earnings: EPS Misses Estimates Sharply Despite Share GainEPS Guidance Update - dars.gov.et
Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRI - TradingView
PTA-Adhoc: Biofrontera AG: Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView
Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView
BFRI|Biofrontera Inc|Price:1.050|Chg%:-0.040 - TradingKey
Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRIW - TradingView
Biofrontera Inc (BFRI) Cash Flow - TradingKey
Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biofrontera Inc (BFRI) Income Statement - TradingKey
Biofrontera Inc (BFRI) Balance Sheet - TradingKey
Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biofrontera Inc (BFRI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biofrontera Inc. Revenue Breakdown – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Holds Steady at $1.09: Consolidation Phase for Micro-Cap Pharma StockInverse ETF Flow - dars.gov.et
Biofrontera Inc (BFRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.66%
0.33%
자본화:
|
볼륨(24시간):